Could effective drug delivery depend not only on getting more therapy into a tumor but also on changing the tumor’s biological response to treatment?
- Built To Avoid Risk: How Industry Norms Stall Drug Discovery
- Does Drug Discovery Anticipate Delivery?
- Antibody–Oligonucleotide Conjugates, Part 3: Analytical Control
- Designing For Precision: How Delivery Is Shaping Cancer Treatment
- Antibody–Oligonucleotide Conjugates, Part 2: Manufacturing
- Intratumoral Treatment Of Cancer: After Many Prior Attempts, Has The Time Finally Come?
- Crossing The Uncrossable: Skin Biology For The Delivery Of Peptide And Protein Therapeutics
- When The Adhesive Becomes The Drug Delivery System
ON-DEMAND WEBINARS
A practical framework for planning and justifying design verification programs for prefillable syringes, covering test selection, acceptance criteria, and sample-size rationale within a risk-based approach.
Nanoparticle engineering enabled a 440 mg/mL trastuzumab suspension that clears viscosity and stability barriers limiting conventional high-dose subcutaneous biologics formulations.
Explore an integrated workflow for targeted lipid nanoparticle development, covering ligand conjugation, candidate screening, and scalable manufacturing for cell-specific nucleic acid delivery.
Modular suites with built-in contamination control streamline sterile manufacturing—supporting complex products, faster timelines, greater flexibility, less disruption, and scalable fill‑finish.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![partnership or agreement in the pharmaceutical industry-GettyImages-2173667078]( "From Early Development To Commercial Launch: An End-To-End Partnership")
From Early Development To Commercial Launch: An End-To-End PartnershipBringing a critical therapy to market takes early coordination. See how strategic planning helped accelerate an oncology therapy from clinical development to patients.
-
![pharmaceutical cleanroom, Heavy Industry Manufacturing Factory-GettyImages-1462154865]( "Unlocking Higher Complex Capsule Yields Through More Efficient Manufacturing")
Unlocking Higher Complex Capsule Yields Through More Efficient ManufacturingBoost complex capsule output by 3–7% per batch with targeted process optimization, without formulation changes, extra batches, new equipment, or regulatory submissions.
-
![science laboratory research, healthcare innovation, development, investigation-GettyImages-1751659695]( "Turning A \"Brick Dust\" Compound Into A Clinically Viable Oral Formulation")
Turning A "Brick Dust" Compound Into A Clinically Viable Oral FormulationAdvanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
-
![Female researcher analyzing scientific samples-GettyImages-2231025177]( "Successful Tech Transfer Plans Ensured On-Time Launches")
Successful Tech Transfer Plans Ensured On-Time LaunchesSuccessful technology transfers require proactive engineering and rigorous assessments to address equipment challenges, protect product integrity, and keep launches on schedule.
-
![GettyImages-1297378718-contamination-gloves-suit-scientist-laboratory]( "Managing Risks With Potent Pharmaceutical Products")
Managing Risks With Potent Pharmaceutical ProductsManufacturing potent medications safely requires specialized containment, toxicology expertise, and strict contamination controls to ensure compliance, product quality, and worker safety.
-
![iStock-459537393-pill-softgel-capsule]( "Is Your API Right For A Soft Gel Capsule?")
Is Your API Right For A Soft Gel Capsule?Soft gel delivery systems can enhance bioavailability, enable controlled release, support combination dosing, and handle potent compounds while improving stability and patient adherence.
-
![GettyImages-1032667996-Softgels]( "How A CDMO Overcomes Soft Gel Formulation Challenges")
How A CDMO Overcomes Soft Gel Formulation ChallengesSoftgel development demands careful control of shell properties, liquid fills, and stability. Overcoming formulation challenges improves drug delivery, bioavailability, and shelf life.
-
![scientist in lab discussing research-GettyImages-2194013442]( "Ensuring Business Continuity In Your Pharmaceutical Commercial Supply")
Ensuring Business Continuity In Your Pharmaceutical Commercial SupplyDrug shortages demand resilient supply chains and strategic partnerships. Learn how experienced manufacturers help mitigate risks and ensure reliable supply.
-
![drug-formulation-GettyImages-155282091]( "Oral Solutions & Suspensions: The Art Of Pharmacy")
Oral Solutions & Suspensions: The Art Of PharmacyOral liquid formulations improve accessibility and dosing flexibility. Learn how developers overcome stability, taste-masking, and manufacturing challenges.
-
![Drug R-D_GettyImages-1483266787]( "Creating A New Dosage Form From An Approved Drug For A New Rare Disease")
Creating A New Dosage Form From An Approved Drug For A New Rare DiseaseAdvancing approved drugs into new indications requires smart formulation, strong quality controls, and regulatory expertise to overcome challenges and accelerate patient access.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Container Closure Systems For Biosimilars: Is There Regulatory Difference?")
Container Closure Systems For Biosimilars: Is There Regulatory Difference?In this article, Fran DeGrazio discusses the FDA’s draft guidance on container closure systems for biosimilar products. She highlights key takeaways and offers recommendations on implications that developers of biosimilar pharmaceutical products should consider in areas such as quality, testing, and documentation.
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts.
